• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于放射免疫闪烁显像和放射免疫治疗的153Sm标记抗癌胚抗原单克隆抗体的生物分布及闪烁显像研究

Biodistribution and scintigraphic studies of 153Sm-labeled anti-CEA monoclonal antibody for radioimmunoscintigraphy and radioimmunotherapy.

作者信息

Fani Melpomeni, Xanthopoulos Stavros, Archimandritis Spyridon C, Stratis Nikolaos, Bouziotis Penelope, Loudos George, Varvarigou Alexandra D

机构信息

Institute of Radioisotopes-Radiodiagnostic Products, National Center for Scientific Research Demokritos, 153 10, Athens, Greece.

出版信息

Anticancer Res. 2003 May-Jun;23(3A):2195-9.

PMID:12894597
Abstract

The anti-CEA monoclonal antibody, which selectively localizes in colon cancer, was labeled with Samarium-153 (153Sm). 153Sm is mainly a beta-emitter which can be used for therapeutic purposes, while its gamma-ray facilitates imaging studies. Labeling was achieved using the bicyclic anhydride of DTPA as chelator for Sm-153 tagging onto the antibody. [153Sm]anti-CEA was biologically evaluated in nude mice bearing tumors of different weight (0.5-2.5 g), at diverse time intervals (4-72 hours), by anatomic and imaging methods. Biodistribution studies showed slow blood clearance and high retention in the liver, kidneys and lungs. In nude mice bearing tumors of about the same weight, uptake increased with time, from 4 to 72 hours post injection (p.i.). Highest uptake was observed in 0.5-0.8 g tumors compared to those of 1.5-2.5 g. The results agreed with imaging studies performed on a gamma camera at 4 to 72 hours p.i. Tumor uptake depended on time and tumor weight. The tumor can be visualized 24 hours p.i. but, due to the high background, it can be clearly distinguished at 72 hours p.i.

摘要

能选择性定位于结肠癌的抗癌胚抗原单克隆抗体用钐 - 153(153Sm)进行标记。153Sm主要发射β射线,可用于治疗目的,而其γ射线有助于成像研究。标记是通过使用二乙三胺五乙酸的双环酸酐作为螯合剂,将Sm - 153标记到抗体上实现的。通过解剖学和成像方法,在不同体重(0.5 - 2.5 g)的荷瘤裸鼠中,于不同时间间隔(4 - 72小时)对[153Sm]抗癌胚抗原进行生物学评估。生物分布研究表明,血液清除缓慢,在肝脏、肾脏和肺中保留率高。在体重大致相同的荷瘤裸鼠中,从注射后(p.i.)4小时到72小时,摄取量随时间增加。与1.5 - 2.5 g的肿瘤相比,在0.5 - 0.8 g的肿瘤中观察到最高摄取量。结果与在注射后4至72小时用γ相机进行的成像研究一致。肿瘤摄取量取决于时间和肿瘤重量。注射后24小时可观察到肿瘤,但由于背景较高,在注射后72小时可清晰分辨。

相似文献

1
Biodistribution and scintigraphic studies of 153Sm-labeled anti-CEA monoclonal antibody for radioimmunoscintigraphy and radioimmunotherapy.用于放射免疫闪烁显像和放射免疫治疗的153Sm标记抗癌胚抗原单克隆抗体的生物分布及闪烁显像研究
Anticancer Res. 2003 May-Jun;23(3A):2195-9.
2
Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study.153Sm-CEA单克隆抗体对荷人结肠癌裸鼠的放射免疫治疗:一项实验研究。
Di Yi Jun Yi Da Xue Xue Bao. 2003 Jan;23(1):1-5.
3
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.一种链霉亲和素 - 抗癌胚抗原抗体、放射性标记生物素预靶向方法用于结直肠癌放射免疫治疗的研发。在人结肠癌异种移植模型中的研究。
Bioconjug Chem. 1997 Jul-Aug;8(4):595-604. doi: 10.1021/bc970101v.
4
Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy.用钐 - 153标记单克隆抗体用于联合放射免疫闪烁成像和放射免疫治疗。
J Nucl Med. 1989 May;30(5):683-91.
5
Labeling of monoclonal antibodies with 153Sm for potential use in radioimmunotherapy.
Appl Radiat Isot. 2002 Nov;57(5):665-74. doi: 10.1016/s0969-8043(02)00181-1.
6
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.(125/131)I-、(186)Re-、(88/90)Y-或(177)Lu标记的抗癌胚抗原单克隆抗体MN-14在结直肠癌源性小腹膜转移小鼠中的生物分布及治疗效果
J Nucl Med. 2004 Jul;45(7):1224-32.
7
[Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].[188Re标记的抗癌胚抗原嵌合抗体在荷人结肠癌裸鼠中的放射免疫检测]
Ai Zheng. 2002 May;21(5):460-3.
8
Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.利用生物制备的双特异性抗癌胚抗原x抗铟标记二乙三胺五乙酸抗体对表达癌胚抗原的肿瘤进行预靶向。
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7130s-7136s. doi: 10.1158/1078-0432.CCR-1004-0006.
9
Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition.
Anticancer Res. 2003 May-Jun;23(3A):2167-71.
10
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.用于结直肠癌放射免疫治疗的链霉亲和素-抗癌胚抗原抗体、放射性标记生物素预靶向方法的开发。试剂开发。
Bioconjug Chem. 1997 Jul-Aug;8(4):585-94. doi: 10.1021/bc970102n.